Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence | Zendy

Joseph P. Broderick | Zendy; Jordan Bonomo | Zendy; Brett Kissela | Zendy; Jane Khoury | Zendy; Charles J. Moomaw | Zendy; Kathleen Alwell | Zendy; Daniel Woo | Zendy; Matthew L. Flaherty | Zendy; Pooja Khatri | Zendy; Opeolu Adeoye | Zendy; Simona Ferioli | Zendy; Dawn Kleindorfer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence

Author(s) -

Joseph P. Broderick,

Jordan Bonomo,

Brett Kissela,

Jane Khoury,

Charles J. Moomaw,

Kathleen Alwell,

Daniel Woo,

Matthew L. Flaherty,

Pooja Khatri,

Opeolu Adeoye,

Simona Ferioli,

Dawn Kleindorfer

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.611905

Subject(s) - medicine , antithrombotic , warfarin , stroke (engine) , population , fibrinolytic agent , ischemic stroke , emergency medicine , atrial fibrillation , intensive care medicine , anesthesia , ischemia , mechanical engineering , environmental health , engineering

Antithrombotic medications (anticoagulants and antiplatelets) are often withheld in the periprocedural period and after bleeding complications to limit the risk of new or recurrent bleeding. These medications are also stopped by patients for various reasons such as cost, side effects, or unwillingness to take medication.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research